Scarica l'app Stockscreener
0.6745
3.83%
0.0245
Precedente Chiudi:
$0.65
Aprire:
$0.668
Volume 24 ore:
51,217
Relative Volume:
0.44
Capitalizzazione di mercato:
$30.28M
Reddito:
$80.28M
Utile/perdita netta:
$-38.83M
Rapporto P/E:
-0.8109
EPS:
-0.8318
Flusso di cassa netto:
$-28.67M
1 W Prestazione:
+4.43%
1M Prestazione:
+0.72%
6M Prestazione:
-22.26%
1 anno Prestazione:
-62.51%
Intervallo 1D:
$0.6501
$0.6804
Intervallo di 1 settimana:
$0.6229
$0.7002
Portata 52W:
$0.5011
$1.87
Tela Bio Inc Stock (TELA) Company Profile
Nome
Tela Bio Inc
Settore
Industria
Telefono
484-320-2930
Indirizzo
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.6745 | 28.70M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
112.54 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.80 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.06 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.74 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.21 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Iniziato | Lake Street | Buy |
| 2019-12-03 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2019-12-03 | Iniziato | Jefferies | Buy |
| 2019-12-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Tela Bio Inc Borsa (TELA) Ultime notizie
TELA Bio (TELA) CEO adds 12,500 shares in August buy - Stock Titan
TELA Bio (TELA) Q2 2026 Earnings Call Transcript - AOL.com
TELA (TELA) Quarter in Focus: The EPS Result Is Below Expectation under the Current Snapshot; Market Response: The Share Price Sheds 1.08% in the Available RecordProduct Revenue Analysis - vinanet.vn
TELA (TELA) Close and Levels: Ends Lower by 1.54% at $0.64 in the Latest Session; Chart Reference: the $0.61 to $0.67 Range Remains in Focus on the DayKAMA Signal - vinanet.vn
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stak - GuruFocus
TELA Bio Pulls 2026 Outlook as Sales Fall, Loss Widens - MyChesCo
TELA Bio (TELA) CEO buys 15,000 shares at $0.6978 - Stock Titan
TELA Bio CEO Heather C. Getz acquires common shares worth $10,467 - Bitget
Tela Bio Earnings Call: Growth Meets Execution Risks - TipRanks
TELA Bio (TELA) stake: Nantahala group reports 12.94% ownership of 5.79M shares - Stock Titan
TELA BIO (TELA): SilverArc Capital and Devesh Gandhi disclose 2.14M-share 4.8% stake - Stock Titan
TELA Bio, Inc. (NASDAQ:TELA) Just Reported And Analysts Have Been Cutting Their Estimates - Moomoo
TELA Stock Price, Quote & Chart - ChartMill
TELA Bio (TELA) Drops 5.86% to $0.68 as Micro-Cap Med-Tech Stock Approaches Critical SupportOvernight Profile - vinanet.vn
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
TELA Bio, Inc. Revenue Breakdown – BOATS:TELA - TradingView
TELA Bio, Inc. 2026: Revenue $19.29M, EPS ($0.2) — 10-Q Summary - TradingView
TELA Bio (NASDAQ: TELA) faces going concern doubt amid debt covenants and cash burn - Stock Titan
TELA Bio loss hits USD 9.3M in Q2 2026 - Medical Buyer
TELA BIO (TELA): SilverArc and Devesh Gandhi report 4.8% ownership stake - Stock Titan
TELA Bio, Inc. Stock 12‑Month Price Target Cut to $2.1, Implies 126% Upside - TradingView
TELA Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 12.4%One-Time Loss Impact - vinanet.vn
Tela Bio earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigati - GuruFocus
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ... - Yahoo Finance
TELA Bio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
TELA Looks 43.6% Undervalued on GF Value™ Despite Operational Un - GuruFocus
Transcript : TELA Bio, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
TELA Bio misses Q2 revenue, withdraws full-year guidance - scanx.trade
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
TELA Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: TELA Bio misses Q2 2026 estimates, withdraws guidance - Investing.com
Is TELA Bio Inc (TELA) Positioned for Recovery After Q2 Earnings Miss? GF Score: 57/100 - GuruFocus
Q2 2026 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook - TradingView
TELA Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
TELA Bio Reports Second Quarter 2026 Financial Results - The Manila Times
BRIEF-TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million - TradingView
TELA Bio Withdraws 2026 Revenue Guidance as Sales Fall 4% - Stock Titan
TELA Bio Names Getz CEO as Founder Koblish Steps Aside - MyChesCo
TELA Bio Inc (TELA) Stock Analysis & Forecast - TradingKey
TELA Bio Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
TELA Bio Inc (TELA) Stock News Today - TradingKey
TELA Bio Inc (TELA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
People on the Move: Heather Getz Joins TELA Bio as Chief Executive Officer - BioBuzz
Earnings To Watch: TELA Bio Inc (TELA) Q2 2026 -- GF Value Sees 97% Upside - Yahoo Finance
TELA Q2'26 Earnings: EPS estimate is (0.17) USD - TradingView
TELA Bio (TELA) Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Commercialization CostsEBITDA Analysis - vinanet.vn
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Large equity grants for TELA Bio, Inc. (TELA) CEO Heather Getz - Stock Titan
TELA Bio, Inc. (TELA) CEO discloses 5,000-share ownership stake - Stock Titan
Tela Bio Inc Azioni (TELA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tela Bio Inc Azioni (TELA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Getz Heather C | Chief Executive Officer |
Aug 14 '26 |
Buy |
0.70 |
15,000 |
10,467 |
520,000 |
| EW HEALTHCARE PARTNERS FUND 2, | 10% Owner |
Nov 17 '25 |
Buy |
1.11 |
3,604,000 |
4,000,440 |
7,714,709 |
0.66%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):